David P Nichols (David Nichols, Dave P Nichols)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Topics

Pseudomonas Aeruginosa

Cystic Fibrosis

Top Venues

Annals of the American Thoracic Society

American journal of respiratory and critical care medicine

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah J Morgan, David P Nichols, Wendy Ni, Gina Hong, Stephen J Salipante, George M Solomon, Steven M Rowe, John P Clancy, Robert A Cramer, Pradeep K Singh, null null
Elexacaftor/Tezacaftor/Ivacaftor Markedly Reduces Aspergillus fumigatus in Cystic Fibrosis. American journal of respiratory and critical care medicine (2024)
Nicole Mayer-Hamblett, Alex H Gifford, Margaret Kloster, Renee Russell, Andrew T Braun, Ronald L Gibson, Jordana E Hoppe, Raksha Jain, Rachel W Linnemann, Theodore G Liou, Jerimiah Lysinger, Carlos Milla, Kristin A Riekert, Gregory S Sawicki, Julia Young, David P Nichols
Impact of Discontinuing Both Hypertonic Saline and Dornase Alfa After Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis. Annals of the American Thoracic Society (2024)
David P Nichols, Alex Gifford, Renee Russell, Katherine Odem-Davis, Julia Young, Rodolfo Amaro-Galvez, Joanne Billings, Zubin Mukadam, Nicole Mayer-Hamblett
Assessing Safety of Discontinuing Hypertonic Saline in Those with Lower FEV1 after Elexacaftor/Tezacaftor/Ivacaftor. Annals of the American Thoracic Society (2023)
David P Nichols, Steven M Rowe
Reply to Martin et al. : Change in Lung Function after Initiation of Elexacaftor-Tezacaftor-Ivacaftor: Do Not Forget Anatomy! American journal of respiratory and critical care medicine 205 (11) (2022)
Jonathan D Cogen, Anna V Faino, Frankline Onchiri, Ronald L Gibson, Lucas R Hoffman, David P Nichols, Margaret Rosenfeld, Matthew P Kronman
Clinical Outcomes of Antipseudomonal versus Other Antibiotics among Children with Cystic Fibrosis without Pseudomonas aeruginosa . Annals of the American Thoracic Society 19 (8) (2022)
David P Nichols, Alex C Paynter, Sonya L Heltshe, Scott H Donaldson, Carla A Frederick, Steven D Freedman, Daniel Gelfond, Lucas R Hoffman, Andrea Kelly, Michael R Narkewicz, Jessica E Pittman, Felix Ratjen, Margaret Rosenfeld, Scott D Sagel, Sarah Jane Schwarzenberg, Pradeep K Singh, George M Solomon, Michael S Stalvey, John P Clancy, Shannon Kirby, Jill M Van Dalfsen, Margaret H Kloster, Steven M Rowe, null null
Clinical Effectiveness of Elexacaftor/Tezacftor/Ivacaftor in People with Cystic Fibrosis. American journal of respiratory and critical care medicine (2021)
David P Nichols, Pradeep K Singh, Arthur Baines, Lindsay J Caverly, James F Chmiel, Ronald L GIbson, Jorge Lascano, Sarah J Morgan, George Retsch-Bogart, Lisa Saiman, Hossein Sadeghi, Joanne L Billings, Sonya L Heltshe, Shannon Kirby, Ada Kong, Jerry A Nick, Nicole Mayer-Hamblett, null null
Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial. Thorax (2021)
Jonathan D Cogen, Anna V Faino, Frankline Onchiri, Lucas R Hoffman, Matthew P Kronman, Maria Nelson, David P Nichols, Margaret Rosenfeld, Donald R VanDevanter, Ronald L Gibson
Association of Inhaled Antibiotics in Addition to Standard Intravenous Therapy and Outcomes of Pediatric Inpatient Pulmonary Exacerbations. Annals of the American Thoracic Society 17 (12) (2021)
Jonathan D Cogen, Anna V Faino, Frankline Onchiri, Ronald L Gibson, Lucas R Hoffman, Matthew P Kronman, Margaret Rosenfeld, David P Nichols
Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation Treatment. Annals of the American Thoracic Society 18 (2) (2021)
Nicole Mayer-Hamblett, David P Nichols, Katherine Odem-Davis, Kristin A Riekert, Greg S Sawicki, Scott H Donaldson, Felix Ratjen, Michael W Konstan, Noah Simon, Daniel B Rosenbluth, George Retsch-Bogart, John P Clancy, Jill M VanDalfsen, Rachael Buckingham, Alex H Gifford
Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design. Annals of the American Thoracic Society 18 (8) (2021)
Jason S Debley, Kaitlyn A Barrow, Lucille M Rich, Pradeep Singh, Edward F McKone, David P Nichols
Correlation between Ivacaftor-induced CFTR Activation in Airway Epithelial Cells and Improved Lung Function: A Proof-of-Concept Study. Annals of the American Thoracic Society 17 (8) (2021)
David P Nichols, Richard B Moss
Early Aspergillosis in Cystic Fibrosis and Air Trapping: Guilt by Association? American journal of respiratory and critical care medicine 201 (6) (2020)
David P Nichols, Katherine Odem-Davis, Jonathan D Cogen, Christopher H Goss, Clement L Ren, Michelle Skalland, Ranjani Somayaji, Sonya L Heltshe
Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis. American journal of respiratory and critical care medicine 201 (4) (2020)
David P Nichols
Breathing Easier: A Well-tolerated Corrector for F508del. American journal of respiratory and critical care medicine 197 (2) (2019)
Natalie E West, Christopher H Goss, David P Nichols
The Long and the Short of It in Cystic Fibrosis Clinical Research Outcomes. Annals of the American Thoracic Society 15 (4) (2018)
Ian T Lamborn, Huie Jing, Yu Zhang, Scott B Drutman, Jordan K Abbott, Shirin Munir, Sangeeta Bade, Heardley M Murdock, Celia P Santos, Linda G Brock, Evan Masutani, Emmanuel Y Fordjour, Joshua J McElwee, Jason D Hughes, David P Nichols, Aziz Belkadi, Andrew J Oler, Corinne S Happel, Helen F Matthews, Laurent Abel, Peter L Collins, Kanta Subbarao, Erwin W Gelfand, Michael J Ciancanelli, Jean Laurent Casanova, Helen C Su
Recurrent rhinovirus infections in a child with inherited MDA5 deficiency. The Journal of experimental medicine 214 (7) (2017)